drugset / Trial / NCT01044251

Frovatriptan as a Transitional Therapy in Medication Overuse Headache

NCT01044251

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will analyze the effectiveness of a medication called Frovatriptan, in the context of medication overuse headache (MOH). MOH is a headache that develops when pain-killers are taken frequently. The treatment is to stop the overuse of these pain-killers, but that can sometimes worsen the headache first before it gets better. We are testing Frovatriptan against placebo to see if it can help patients with this transition and avoid the worsening of the headache that can occur. We will also see if Frovatriptan can help in other ways, such as maintain patients free of medication overuse.

Timeline

Start
2010-01
Primary completion
2019-04-17
Completion
2019-04-17

Drugs

EvaluationDrugModalityDoseRoute
Subject Frovatriptan Small molecule 2.5 mg Oral

Indications

No indication recorded.